Prognostic significance of overexpressed long non-coding RNA TUG1 in patients with clear cell renal cell carcinoma

被引:2
作者
Wang, P. -Q. [1 ]
Wu, Y. -X. [1 ]
Zhong, X. -D. [1 ]
Liu, B. [1 ]
Qiao, G. [1 ]
机构
[1] Linzi Dist Peoples Hosp, Dept Crit Care Med, Zibo, Shandong, Peoples R China
关键词
Long non-coding RNAs; TUG1; Clear cell renal cell carcinoma; Prognosis; POOR-PROGNOSIS; CANCER; GROWTH; EXPRESSION; APOPTOSIS; PREDICTS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The long non-coding RNAs (lncRNAs) study has gradually become one of the hot topics in the field of RNA biology. However, little is known about the pathological role of lncRNA TUG1 in clear cell renal cell carcinoma (ccRCC) patients. This study attempted to investigate the association of lncRNA TUG1 expression with progression and prognosis in ccRCC patients. PATIENTS AND METHODS: Using qRT-PCR, the expression of TUG1 was measured in 203 ccRCC tissues and 45 adjacent non-cancerous tissues. Then, the relationships between TUG1 level and the clinicopathological factors of patients with ccRCC were analyzed. The prognostic significance was evaluated using Kaplan-Meier and Cox regression analyses. RESULTS: The relative level of TUG1 was significantly higher in ccRCC tissues compared to the adjacent non-tumor tissues (p < 0.01). Furthermore, TUG1 was associated significantly with histological grade, tumor stage, lymph node metastasis and distant metastasis (all p < 0.05). Interestingly, Kaplan-Meier analysis showed that higher TUG1 expression levels were associated with a shorter overall survival (p < 0.001) in ccRCC patients. Cox proportional hazards analysis showed that high TUG1 expression was an independent prognostic marker of poor outcome. CONCLUSIONS: These findings suggested that TUG1 may act as a tumor promoter in ccRCC and could serve as a potential therapeutic target for this tumor.
引用
收藏
页码:82 / 86
页数:5
相关论文
共 18 条
[1]   LncRNADisease: a database for long-non-coding RNA-associated diseases [J].
Chen, Geng ;
Wang, Ziyun ;
Wang, Dongqing ;
Qiu, Chengxiang ;
Liu, Mingxi ;
Chen, Xing ;
Zhang, Qipeng ;
Yan, Guiying ;
Cui, Qinghua .
NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) :D983-D986
[2]  
Cheng WS, 2014, EUR REV MED PHARMACO, V18, P3504
[3]  
Ellinger J, 2015, AM J CANCER RES, V5, P2799
[4]   Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis [J].
Gupta, Rajnish A. ;
Shah, Nilay ;
Wang, Kevin C. ;
Kim, Jeewon ;
Horlings, Hugo M. ;
Wong, David J. ;
Tsai, Miao-Chih ;
Hung, Tiffany ;
Argani, Pedram ;
Rinn, John L. ;
Wang, Yulei ;
Brzoska, Pius ;
Kong, Benjamin ;
Li, Rui ;
West, Robert B. ;
van de Vijver, Marc J. ;
Sukumar, Saraswati ;
Chang, Howard Y. .
NATURE, 2010, 464 (7291) :1071-U148
[5]   Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2 [J].
Huang, Ming-De ;
Chen, Wen-Ming ;
Qi, Fu-Zhen ;
Sun, Ming ;
Xu, Tong-Peng ;
Ma, Pei ;
Shu, Yong-qian .
MOLECULAR CANCER, 2015, 14
[6]  
JEMAL A, 2011, CA-CANCER J CLIN, V61, P134, DOI [DOI 10.3322/CAAC.20107, DOI 10.3322/caac.20115]
[7]   EAU Guidelines on Renal Cell Carcinoma: The 2010 Update [J].
Ljungberg, Borje ;
Cowan, Nigel C. ;
Hanbury, Damian C. ;
Hora, Milan ;
Kuczyk, Markus A. ;
Merseburger, Axel S. ;
Patard, Jean-Jacques ;
Mulders, Peter F. A. ;
Sinescu, Ioanel C. .
EUROPEAN UROLOGY, 2010, 58 (03) :398-406
[8]   Renal cell carcinoma: etiology, incidence and epidemiology [J].
Murai, M ;
Oya, M .
CURRENT OPINION IN UROLOGY, 2004, 14 (04) :229-233
[9]   Renal cell carcinoma [J].
Rini, Brian I. ;
Campbell, Steven C. ;
Escudier, Bernard .
LANCET, 2009, 373 (9669) :1119-1132
[10]  
Russo P, 2000, SEMIN ONCOL, V27, P160